Point72 Asset Management’s Krystal Biotech KRYS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-15,299
| Closed | -$1.9M | – | 1675 |
|
2023
Q4 | $1.9M | Sell |
15,299
-682,859
| -98% | -$84.7M | ﹤0.01% | 862 |
|
2023
Q3 | $81M | Buy |
698,158
+138,897
| +25% | +$16.1M | 0.24% | 80 |
|
2023
Q2 | $65.7M | Buy |
559,261
+56,861
| +11% | +$6.68M | 0.2% | 128 |
|
2023
Q1 | $40.2M | Sell |
502,400
-53,852
| -10% | -$4.31M | 0.12% | 194 |
|
2022
Q4 | $44.1M | Sell |
556,252
-702,253
| -56% | -$55.6M | 0.15% | 171 |
|
2022
Q3 | $87.7M | Sell |
1,258,505
-315,770
| -20% | -$22M | 0.35% | 56 |
|
2022
Q2 | $103M | Sell |
1,574,275
-145,992
| -8% | -$9.59M | 0.44% | 38 |
|
2022
Q1 | $114M | Sell |
1,720,267
-135,889
| -7% | -$9.04M | 0.45% | 31 |
|
2021
Q4 | $130M | Buy |
1,856,156
+1,321,456
| +247% | +$92.4M | 0.52% | 19 |
|
2021
Q3 | $27.9M | Buy |
534,700
+193,800
| +57% | +$10.1M | 0.12% | 211 |
|
2021
Q2 | $23.2M | Buy |
340,900
+171,900
| +102% | +$11.7M | 0.1% | 235 |
|
2021
Q1 | $13M | Sell |
169,000
-331,000
| -66% | -$25.5M | 0.06% | 353 |
|
2020
Q4 | $30M | Sell |
500,000
-163,889
| -25% | -$9.83M | 0.15% | 183 |
|
2020
Q3 | $28.6M | Buy |
663,889
+124,647
| +23% | +$5.37M | 0.15% | 192 |
|
2020
Q2 | $22.3M | Buy |
+539,242
| New | +$22.3M | 0.15% | 189 |
|
2019
Q3 | – | Sell |
-101,700
| Closed | -$4.1M | – | 1245 |
|
2019
Q2 | $4.1M | Buy |
101,700
+17,616
| +21% | +$709K | 0.02% | 480 |
|
2019
Q1 | $2.77M | Buy |
+84,084
| New | +$2.77M | 0.01% | 573 |
|